Table 1. Correlations of PRDX1 expression with clinicopathological variables of osteosarcoma in training and validation cohort.
Variables | Training Cohort | Validation Cohort | ||||||
---|---|---|---|---|---|---|---|---|
PRDX1 Expression | PRDX1 Expression | |||||||
N | Low | High | P value | No. | Low | High | P value | |
Gender | ||||||||
Male | 75 | 31 | 44 | 0.676 | 67 | 22 | 45 | 0.584 |
Female | 35 | 13 | 22 | 23 | 9 | 14 | ||
Age (years) | ||||||||
< 45 | 57 | 20 | 37 | 0.275 | 54 | 19 | 35 | 0.856 |
> 45 | 53 | 24 | 29 | 36 | 12 | 24 | ||
Anatomical site | ||||||||
Femur/Tibia | 89 | 36 | 53 | 0.843 | 67 | 21 | 46 | 0.291 |
Elsewhere | 21 | 8 | 13 | 23 | 10 | 13 | ||
Tumor size (cm) | ||||||||
< 8 | 50 | 30 | 20 | < 0.001 | 41 | 22 | 19 | < 0.001 |
> 8 | 60 | 14 | 46 | 49 | 9 | 40 | ||
ALP level(U/L) | ||||||||
< 150 | 44 | 16 | 28 | 0.525 | 31 | 11 | 20 | 0.880 |
> 150 | 66 | 28 | 38 | 59 | 20 | 39 | ||
Pathological fracture | ||||||||
Absent | 91 | 41 | 50 | 0.018 | 69 | 27 | 17 | < 0.001 |
Present | 19 | 3 | 16 | 21 | 4 | 42 | ||
Ennecking grade | ||||||||
2a | 61 | 30 | 31 | 0.028 | 47 | 23 | 24 | 0.002 |
2b | 49 | 14 | 35 | 43 | 8 | 35 | ||
Histologic grade | ||||||||
Low | 65 | 33 | 32 | 0.006 | 47 | 24 | 23 | 0.001 |
High | 45 | 11 | 34 | 44 | 8 | 36 | ||
TNM stage | ||||||||
I/II | 62 | 32 | 30 | 0.005 | 47 | 25 | 22 | < 0.001 |
III | 48 | 12 | 36 | 43 | 6 | 37 |